Cargando…
Geniposide Alleviates Glucocorticoid-Induced Inhibition of Osteogenic Differentiation in MC3T3-E1 Cells by ERK Pathway
Glucocorticoid (GC) therapy is the leading cause of secondary osteoporosis and the therapeutic and preventative drugs for GC-induced osteoporosis are limited. In this study, we investigated the protective effects of geniposide on dexamethasone (DEX)-induced osteogenic inhibition in MC3T3-E1 cells. T...
Autores principales: | Xie, Baocheng, Wu, Jiahuan, Li, Yongmei, Wu, Xuejun, Zeng, Zhanwei, Zhou, Chenhui, Xu, Daohua, Wu, Longhuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482204/ https://www.ncbi.nlm.nih.gov/pubmed/31057410 http://dx.doi.org/10.3389/fphar.2019.00411 |
Ejemplares similares
-
Kaempferol Ameliorates the Inhibitory Activity of Dexamethasone in the Osteogenesis of MC3T3-E1 Cells by JNK and p38-MAPK Pathways
por: Xie, Baocheng, et al.
Publicado: (2021) -
Epimedin C Alleviates Glucocorticoid-Induced Suppression of Osteogenic Differentiation by Modulating PI3K/AKT/RUNX2 Signaling Pathway
por: Xu, Yongxiang, et al.
Publicado: (2022) -
Editorial: Bone and Cartilage Diseases—The Role and Potential of Natural Products
por: Xu, Daohua, et al.
Publicado: (2022) -
Editorial: Bone and Cartilage Diseases – The Role and Potential of Natural Products, Volume II
por: Pei, Ming, et al.
Publicado: (2023) -
miR-365 Ameliorates Dexamethasone-Induced Suppression of Osteogenesis in MC3T3-E1 Cells by Targeting HDAC4
por: Xu, Daohua, et al.
Publicado: (2017)